Taro Pharmaceutical Industries Ltd (NYSE:TARO)

37.00
Delayed Data
As of Dec 01
 +1.00 / +2.78%
Today’s Change
22.89
Today|||52-Week Range
42.22
+27.41%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 35.00, with a high estimate of 35.00 and a low estimate of 35.00. The median estimate represents a -5.41% decrease from the last price of 37.00.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.32
Sales
$155.0M
Reporting Date
Feb 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 39.13%
 
 
 
 
 
 
Growthannually 86.76%
 
 
 
 
 

Sales

Growthquarterly 4.59%
 
 
 
 
 
 
Growthannually 7.50%
 
 
 
 
 
Key to the earnings and sales forecast charts.